Search Results 1961-1970 of 17073 for monoclonal antibody

1. WEE1 Inhibitor AZD1775 With or Without Cytarabine in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome - Mayo Clinic

   Cytotoxic chemotherapy ≤14 days prior to registration · Immunotherapy ≤ 14 days prior to registration · Biologic therapy (i.e. antibody therapies) ≤ 14 days ...

2. Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Study - Mayo Clinic

   chimeric or humanized antibodies - Active tuberculosis (purified protein derivative [PPD] response without active tuberculosis [TB] is allowed)

3. Neoadjuvant dual checkpoint blockade with PD1 and LAG-3 inhibition in resectable Non-small cell lung Cancer - Mayo Clinic

   Patients who are known hepatitis C virus antibody positive (HCV Ab+) who have controlled infection (undetectable HCV RNA by PCR either spontaneously or in ...

4. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

   Has a known history of HIV (HIV 1/2 antibodies); Has known active Hepatitis B (e.g., Hepatitis B Surface Antigen [HBsAg] reactive) or Hepatitis C (e.g. ...

5. American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic Vasculitis - Mayo Clinic

   ... antibodies [ANCA]), and are now not consistent with some of the current disease definitions. Therefore to progress future research in vasculitis, it is ...

6. Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation - Mayo Clinic

   - Prior treatment with an anti-EGFR antibody (e.g., cetuximab or panitumumab). - Active brain metastasis. Note: Other protocol defined Inclusion/Exclusion ...

7. Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone as First-line Treatment in Participants With Metastatic Leiomyosarcoma - Mayo Clinic

   For Hepatitis C, this includes positive tests for both Hepatitis C antibody and quantitative Hepatitis C PCR. 4. Active uncontrolled infection. 5. Any other ...

8. Health Topics - Mayo Clinic News Network

   Mayo Clinic Q&A podcast: Herd immunity, antibodies and COVID-19. Jennifer O'Hara. July 31, 2020. Sharing Mayo Clinic. Voices of Mayo: Matthew Horace on Race in ...

9. International Group Publishes Updated Criteria for Diagnosing Multiple Myeloma

   Rajkumar said multiple myeloma is always preceded sequentially by two asymptomatic conditions, monoclonal gammopathy of undetermined significance (MGUS) and ...

10. Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis - Mayo Clinic

    ... antibodies at Screening, no history of positive HCV RNA result, and documentation that no anti-HCV therapy has been received);; PBC, primary sclerosing ...